SLC9C1, the official full name is solute carrier family 9 member C1, it’s also known as SLC9A10 or NHE-10. It is encoded by the SLC9C1 gene in humans, which is conserved in chimpanzee, mouse, and dog. It has been reported that 113 organisms have orthologs with this gene. SLC9C1 belongs to solute carrier family 9 or sodium-hydrogen exchanger (NHE) family, and is biased expressed in testis, skin and is involved in male fertility and sperm motility.
|Basic Information of SLC9C1|
|Protein Name||Sodium/hydrogen exchanger 10|
|Aliases||Na(+)/H(+) exchanger 10, NHE-10, Solute carrier family 9 member 10, Solute carrier family 9 member C1, Sperm-specific Na(+)/H(+) exchanger, sNHE, SLC9A10|
|Organism||Homo sapiens (Human)|
SLC9C1 is also known as solute carrier family 9 member 10 (NHE10) which belongs to sodium-hydrogen exchanger (NHE) family. It was identified to be biased expressed in testis and skin. SLC9C1 is required for male fertility and sperm motility as a sperm-specific plasmalemmal NHE. In 2008, a study found that SLC9C1 is highly expressed in osteoclasts in response to NF-kB signaling, indicating that SLC9C1 is involved in osteoclast differentiation and survival. Also, the expression of SLC9C1 is associated with Dent’s disease identified in a mouse model. In addition, the identified mutation of SLC9C1 may be associated with asthenozoospermia in humans. Furthermore, inhibition of NHEs can prevent sRANKL-promoted cellular fusion. And anti-SLC9C1 monoclonal antibody can be used to inhibit bone resorption for targeted bone disease therapy. For the role of SLC9C1 in sperm function and fertilization in mammals, it is the impaired cAMP synthesis which can reduce motility deficiency, rather than intracellular pH signaling.
Fig.1 Models of SLC9C1 gating by voltage and cAMP. (Windler, 2018)
This article indicates that SLC9C1 is a phylogenetic chimaera which can combine the gating mechanism of ion channels and the ion-exchange mechanism of solute carriers. It can enable downstream signaling events through a rapid pH response.
This article shows that anti-NHE10 monoclonal antibody can be used to inhibit bone resorption for targeted bone disease therapy.
This article introduces the functional roles of SLC9 sodium/hydrogen exchangers including SLC9C1.
This article shows that the transcription level of SLC9C1 is affected in Dent's disease, an X-linked renal tubular disorder.
This article shows that SLC9C1 is required for osteoclast differentiation and survival.
With years of extensive experience, we have established advanced Magic™ membrane protein production platform, to provide superior transmembrane protein preparation services to facilitate your projects. Aided by our versatile Magic™ anti-membrane protein antibody discovery platform, we also provide customized anti-SLC9C1 antibody development services.
Creative Biolabs aims to offer the most superior services to our customers to best maximize the success of your projects. With senior scientists and experienced team, we are glad to provide customized services as per your specific requirements. For more detailed information, please feel free to contact us.